Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.36 EUR | -0.83% | -3.69% | -27.56% |
04-24 | Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-22 | Adocia: announces fund-raising | CF |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company has a low valuation given the cash flows generated by its activity.
- For several months, analysts have been revising their EPS estimates roughly upwards.
Weaknesses
- The company's enterprise value to sales, at 6.62 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.56% | 129M | - | ||
-2.63% | 103B | B+ | ||
+1.62% | 95.28B | B+ | ||
+1.46% | 22.15B | B | ||
-16.67% | 21.02B | B+ | ||
-8.58% | 18.15B | A- | ||
-38.74% | 16.73B | A- | ||
-13.21% | 16.05B | B | ||
+5.41% | 13.68B | C+ | ||
+33.57% | 12.17B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ADOC Stock
- Ratings Adocia